Literature DB >> 24408886

Analysis of FMR1 deletion in a subpopulation of post-mitotic neurons in mouse cortex and hippocampus.

Anahita Amiri1, Efrain Sanchez-Ortiz, Woosung Cho, Shari G Birnbaum, Jing Xu, Renée M McKay, Luis F Parada.   

Abstract

Fragile X syndrome (FXS) is the most common form of inherited mental retardation and the leading cause of autism. FXS is caused by mutation in a single gene, FMR1, which encodes an RNA-binding protein FMRP. FMRP is highly expressed in neurons and is hypothesized to have a role in synaptic structure, function, and plasticity by regulating mRNAs that encode pre- and post-synaptic proteins. Fmr1 knockout (KO) mice have been used as a model to study FXS. These mice have been reported to show a great degree of phenotypic variability based on the genetic background, environmental signals, and experimental methods. In this study, we sought to restrict FMRP deletion to two brain regions that have been implicated in FXS and autism. We show that ablating Fmr1 in differentiated neurons of hippocampus and cortex results in dendritic alterations and changes in synaptic marker intensity that are brain region specific. In our conditional mutant mice, FMRP-deleted neurons have activated AKT-mTOR pathway signaling in hippocampus but display no apparent behavioral phenotypes. These results highlight the importance of identifying additional factors that interact with Fmr1 to develop FXS.
© 2013 International Society for Autism Research, Wiley Periodicals, Inc.

Entities:  

Keywords:  Fmr1; Fragile X Syndrome; Nse-Cre; autism; mental retardation; synaptic plasticity

Mesh:

Substances:

Year:  2014        PMID: 24408886     DOI: 10.1002/aur.1342

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  7 in total

Review 1.  Pharmacotherapy for Fragile X Syndrome: Progress to Date.

Authors:  Matthew H Davenport; Tori L Schaefer; Katherine J Friedmann; Sarah E Fitzpatrick; Craig A Erickson
Journal:  Drugs       Date:  2016-03       Impact factor: 9.546

Review 2.  Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

Authors:  S W Hulbert; Y-H Jiang
Journal:  Neuroscience       Date:  2015-12-28       Impact factor: 3.590

3.  Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.

Authors:  Haruki Higashimori; Christina S Schin; Ming Sum R Chiang; Lydie Morel; Temitope A Shoneye; David L Nelson; Yongjie Yang
Journal:  J Neurosci       Date:  2016-07-06       Impact factor: 6.167

Review 4.  Long-term Synaptic Plasticity: Circuit Perturbation and Stabilization.

Authors:  Joo Min Park; Sung-Cherl Jung; Su-Yong Eun
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

Review 5.  A Subset of Autism-Associated Genes Regulate the Structural Stability of Neurons.

Authors:  Yu-Chih Lin; Jeannine A Frei; Michaela B C Kilander; Wenjuan Shen; Gene J Blatt
Journal:  Front Cell Neurosci       Date:  2016-11-17       Impact factor: 5.505

Review 6.  Fragile X targeted pharmacotherapy: lessons learned and future directions.

Authors:  Craig A Erickson; Matthew H Davenport; Tori L Schaefer; Logan K Wink; Ernest V Pedapati; John A Sweeney; Sarah E Fitzpatrick; W Ted Brown; Dejan Budimirovic; Randi J Hagerman; David Hessl; Walter E Kaufmann; Elizabeth Berry-Kravis
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

Review 7.  Mouse Genetic Models of Human Brain Disorders.

Authors:  Celeste Leung; Zhengping Jia
Journal:  Front Genet       Date:  2016-03-23       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.